“The Pharmaceutical industry will be sustainable & successful only if it is available and affordable to all� a line that our late chairman Mr. B.C. Sanghavi said a number of times in his 50 year career in healthcare.

Mr. B.C. Sanghavi, began his career in pharmaceuticals in bulk drug manufacturing, having a world class manufacturing facility in Mumbai. The main products manufactured were para hydroxy acetophenone and para hydroxy phenyl acetamide which were intermediates in the manufacturing of Atenolol.

Gradually over the years as China became one of the main players in the API and intermediates, our focus shifted to manufacturing of finished products. In the late 90’s, the company became one of the premier manufacturers of Ampicillin and Amoxycillin dry syrups having a nation wide distribution channel.

In the early 2000’s, the goal of the company shifted to the overseas markets. It decided to make a global mark in the pharmaceutical footprint of the world. Labdhi Pharmaceuticals was formed as a 100% export oriented firm with a vision to cater to the drug shortages of niche molecules in the un-regulated and semi-regulated markets. In 2015, Labdhi Pharmaceuticals becomes a Government recognised Star Export House.